GMax™ Liposome3000 Transfection Reagent (Synonyms: Lipo8000) |
Katalog-Nr.GK20006 |
Das Transfektionsreagenz GMax™ Liposome3000 enthält Liposom-Nanopartikel-Technologie, die eine hervorragende Transfektionsleistung bieten kann und die Ergebnisse sowie Reproduzierbarkeit von verwandten Anwendungen verbessert.
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
- Cell Cycle 21.3 (2022):228-246.PMID:34965191
- Front Microbiol 13 (2022):944101.PMID:35992663
- Bmc Biol 22 (2024):264.PMID:39563372
- J Hepatocell Carcino (2025):427-444.PMID:40040881
- Biol Reprod (2024):ioae167.PMID:39563514
- Immun Inflamm Dis 11.6 (2023):e883.PMID:37382273
- Mol Cell Biochem 476.10 (2021):3757-3769.PMID:34097192
- J Cardiothorac Surg 18.1 (2023):222.PMID:37420297
- Bmc Med Genomics 17.1 (2024):238.PMID:39350129
- Front Cell Dev Biol 9 (2021):727822.PMID:34790659
- Heliyon (2024).
- eGastroenterology 2.1 (2024).
- Front Genet 15 (2024):1308737.
- Eur J Pharmacol 940 (2023):175391.PMID:36400161
GMax™ Liposome3000 Transfection Reagent contains liposome nanoparticle technology, which can provide excellent transfection performance and improve the results and reproducibility of related applications. This reagent has excellent transfection efficiency and can improve cell activity, and is widely used in difficult to transfect and common cell types (such as HEK293 and Hela cells). In the process of successfully transfecting a wide range of cell types related to biological research, this reagent can:
• Provides excellent performance-our reagents that achieve the highest transfection efficiency for cell types that are difficult to transfect (the cell types that can be efficiently transfected include: fibroblasts (3T3, COS-7), myoblasts (C2C12 , L6 CRL-1458), liver cells (HepG2, HuH7), red leukemia cells (K562), breast cancer (MCF7, Hs578T), prostate cancer (LNCap), lung cancer cells (A549, NCI-H460), osteosarcoma cells ( U-2 OS, Saos-2), colon cancer cells (Caco2, SW480), pancreatic cancer cells (PANC-1) Skin melanoma cells(SK-MEL-28)
• Improve cell activity-gentle on cells and very low toxicity (this liposome dosage can maintain a high transfection efficiency in a wide dynamic range, and can be optimized easily and quickly as needed. For related applications where damage is minimized, the use of low-toxic liposomes is recommended)
1. Cell preparation
Adherent cells: It is recommended to plate the cells one day before transfection and use antibiotic-free medium to inoculate the cells so that they can reach 70-90% confluence the next day.
Suspension cells: It is recommended that the cell density reach 2-4×106/ml on the day of transfection.
2. Lipo3000 Transfection Reagent transfection protocol
3. Transfection of siRNA
When transfecting siRNA into cells, follow the DNA transfection protocol above, except there is no need to add P3000 when diluting siRNA (step 3).
4. Recommended table of media, nucleic acids and Lipo3000 dosage for transfection in different cell culture plates
Precautions:
1. Cells should be in good growth status during transfection. It is recommended that the cell density reach 70-80% during transfection.
2. For most cells, higher cell density during transfection can achieve high transfection efficiency and expression level, and reduce a certain amount of cytotoxicity.
3. For adherent cells, it is recommended to perform transfection 12-24 hours after plating. At this time, the cells are in good adhesion.
4. The cell status, DNA or siRNA in each experiment are different to a certain extent. It is recommended to explore the best conditions through preliminary experiments, especially the dosage of transfection reagent, and set up positive controls and negative controls at the same time.
5. Pay attention to the dosage ratio of liposomes and plasmids during transfection. Excessive liposomes will cause greater toxicity to the cells, leading to experimental failure. In order to achieve the highest transfection efficiency and lowest cytotoxicity, the ratio of DNA and Lipo3000 and cell density can be optimized. Generally, the ratio of DNA (μg) and Lipo3000 (μl) is optimized in the range of 1:0.5~1:5.
6. The DNA or RNA required for transfection must be of high purity and high quality to achieve higher transfection efficiency. The appropriate plasmid concentration for transfection is 0.5-5μg/μL, and there is no contamination by endotoxin, protein, RNA or other chemical substances.
7. The serum in the culture medium will affect the formation of liposome complexes. It is recommended to use serum-free Opti-MEM serum-reduced medium to configure the transfection system. The serum in the cell culture medium will not affect the transfection efficiency.
8. In order to improve the transfection efficiency, it is recommended to use antibiotic-free medium to inoculate cells when plating before transfection, and to replace the medium with low serum (2%), antibiotic-free medium 2 hours before transfection. Starvation treatment and replacement with complete culture medium 4-6 hours after transfection can greatly improve the transfection efficiency.
9. If you need to screen for stably transfected cell lines, it is recommended to inoculate the cells into fresh medium at a ratio of 1:10 or higher 24 hours after transfection, and change to selective medium for screening the next day. It is recommended to select corresponding drugs according to the resistance markers contained in different gene vectors. Commonly used markers in eukaryotic expression gene vectors include hygromycin and neomycin.
Components | 0.25 mL | 0.75 mL |
GMax™ Liposome3000 Transfection Reagent | 0.25 mL | 0.75 mL |
GMax™ P-3000 Reagent | 0.25 mL | 0.75 mL |
Store at 4°C. Do not freeze. |
- View current batch:
Average Rating: 5
(Based on Reviews and 39 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *